Rahul Aggarwal, MD

Developmental therapeutics specialist
Genitourinary oncologist

Dr. Rahul Aggarwal is a genitourinary cancer specialist at the UCSF Helen Diller Family Comprehensive Cancer Center. He also serves as director of the UCSF STAND (Supportive Therapy in Androgen Deprivation) Clinic, which provides comprehensive care to men with prostate cancer who are receiving androgen deprivation therapy, also known as hormone therapy. In addition, as a member of the Developmental Therapeutics Genitourinary Cancer Program, Aggarwal enrolls patients with advanced solid tumor malignancies into early phase clinical trials of novel targeted treatments. His research is focused on developing novel hormonal treatment strategies that reduce the toxicity of androgen deprivation therapy for men with advanced prostate cancer. Aggarwal is also interested in developing novel molecular imaging techniques as a prognostic and predictive biomarker of tumor response among patients with advanced solid tumors.

Aggarwal earned a medical degree from Northwestern University Feinberg School of Medicine. Subsequently, he completed an internship and residency in internal medicine followed by a clinical fellowship in hematology/oncology at UCSF. Aggarwal was also a research fellow in developmental therapeutics at Genentech, Inc. in South San Francisco. He is a member of the American Society of Clinical Oncology (ASCO) and recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award. Aggarwal is an assistant clinical professor of medicine at UCSF.

Clinics

Genitourinary Medical Oncology
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 476-4616
Fax: (415) 353-7107

Hours: Monday to Friday
8 a.m. – 5 p.m.

STAND Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 885-7795
Fax: (415) 353-7093

Board Certification

Internal Medicine, American Board of Internal Medicine

Academic Title

Assistant Professor

More about Rahul Aggarwal

Education

Northwestern University Feinberg School of Medicine 2006

Residencies

UCSF Medical Center, Internal Medicine 2009

Fellowships

UCSF Medical Center, Hematology/Oncology 2013

Selected Research and Publications

  1. Chen HY, Larson PEZ, Gordon JW, Bok RA, Ferrone M, van Criekinge M, Carvajal L, Cao P, Pauly JM, Kerr AB, Park I, Slater JB, Nelson SJ, Munster PN, Aggarwal R, Kurhanewicz J, Vigneron DB. Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer. Magn Reson Med. 2018 Mar 25.
  2. Wei XX, Siegel AP, Aggarwal R, Lin AM, Friedlander TW, Fong L, Kim W, Louttit M, Chang E, Zhang L, Ryan CJ. A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone- and/or Enzalutamide-Refractory Metastatic Castration-Resistant Prostate Cancer. Oncologist. 2018 Feb 27.
  3. Aggarwal R. Defining the Prognostic and Predictive Impact of Germline DNA Repair Mutations in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2018 Feb 16.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.